. "For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis."@en . "Various Fungus Species"@en . . . . "Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]"@en . . "7681-93-8"@en . . . . "Natamycin"@en . . "Pimaricin"@en . . . . . . . . . . . "Natamicina"@en . . . . . . . . . . . . "approved"@en . . . "Systemic absorption should not be expected following topical administration, and as with other polyene antibiotics, absorption from the gastrointestinal tract is very poor."@en . . "LIke other polyene antibiotics, Natamycin inhibits fungal growth by binding to sterols. Specifically, Natamycin binds to ergosterol in the plasma membrane, preventing ergosterol-dependent fusion of vacuoles, as well as membrane fusion and fission. This differs from the mechanism of most other polyene antibiotics, which tend to work by altering fungal membrane permeability instead."@en . . . . . "PMR"@en . " "@en . . "Michael A. Eisenschink, Phillip T. Olson, \"Fermentation process for producing natamycin.\" U.S. Patent US5231014, issued July, 1982."@en . . "Natacyn"@en . . . "Natamycine"@en . . . . "Natamycin"@en . . . . . . . . . "Natamycinum"@en . .